Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Interest Coverage Ratio (2016)

Historic Interest Coverage Ratio for Heron Therapeutics (HRTX) over the last 3 years, with Q4 2016 value amounting to 63.56.

  • Heron Therapeutics' Interest Coverage Ratio changed N/A to 63.56 in Q4 2016 from the same period last year, while for Sep 2017 it was 128.27, marking a year-over-year change of. This contributed to the annual value of 1.91 for FY2024, which is 9331.71% up from last year.
  • According to the latest figures from Q4 2016, Heron Therapeutics' Interest Coverage Ratio is 63.56.
  • In the past 5 years, Heron Therapeutics' Interest Coverage Ratio registered a high of 23.61 during Q1 2012, and its lowest value of 74.19 during Q2 2013.
  • For the 3-year period, Heron Therapeutics' Interest Coverage Ratio averaged around 57.08, with its median value being 63.44 (2013).
  • Within the past 5 years, the most significant YoY rise in Heron Therapeutics' Interest Coverage Ratio was 16872.39% (2013), while the steepest drop was 16872.39% (2013).
  • Over the past 3 years, Heron Therapeutics' Interest Coverage Ratio (Quarter) stood at 23.61 in 2012, then crashed by 156.65% to 60.59 in 2013, then dropped by 4.89% to 63.56 in 2016.
  • Its Interest Coverage Ratio stands at 63.56 for Q4 2016, versus 60.59 for Q3 2013 and 74.19 for Q2 2013.